Clinical Trials Logo

Filter by:
NCT ID: NCT03053011 Completed - Healthy Volunteers Clinical Trials

Evaluation of the Awakening Capability by a Vibrating Bracelet (BRASSARD)

BRASSARD
Start date: February 13, 2017
Phase: N/A
Study type: Interventional

As part of developing a relay alarm project, the aim of the study is to test a sleeper's capability to wake up via a vibrating alarm around the wrist (vibrating bracelet).

NCT ID: NCT03052855 Completed - Depression Clinical Trials

Inflammatory Biomarkers and Brain Metabolites, a Study Based on Magnetic Resonance Spectroscopy

BICS
Start date: February 1, 2017
Phase: N/A
Study type: Interventional

Suicidal behaviors (SB) are a major health problem in France : 10 000 suicides and 220 000 suicide attempts every year. SB management is therefore a major public health issue. Evidence associated dysregulation of the serotonergic system and the hypothalamic-pituitary-adrenal axis to vulnerability to SB. Recent data point to linke these abnormalities with neuroinflammatory clues, glutamatergic function and neuronal plasticity. There is a need to better understand the physiopathology and develop diagnostic and therapeutic tools in SB. The investigators hypothesize that increased peripheral biomarkers of inflammation would correlate to a disturbance of the cerebral metabolites, such as glutamate and NAA, especially in suicidal patients. Our aim is to compare rates of cerebral metabolites, in particular the complex glutamine/glutamate, in cerebral areas involved in suicidal vulnerability (the anterior cingulate cortex and the orbito-frontal cortex) between person with unipolar disorder with and without suicidal attempt.

NCT ID: NCT03052803 Completed - Clinical trials for Coronary Artery Disease

Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries

FFR-DS
Start date: February 1, 2017
Phase: N/A
Study type: Observational

The aim of the study is to compare different devices available to measure fractional flow reserve (FFR) in coronary arteries.

NCT ID: NCT03052556 Completed - Cystic Fibrosis Clinical Trials

Human Papillomavirus and Cervical Dysplasia in Women With Cystic Fibrosis

MUCOHPV
Start date: March 8, 2017
Phase: N/A
Study type: Interventional

Background The main risk factor for cervical cancer is the infection by human papillomavirus (HPV), with several intermediate steps between HPV infection and cervical cancer. Cervical screening with pap smear test and HPV vaccination are effective preventions. A high frequency of HPV carriage and of cervical dysplasia have been described in transplanted women. The majority of women with cystic fibrosis reach adulthood and some will face transplantation. Particular attention should therefore be paid to cervical screening. However, low adherence to screening recommendations was noted. In addition, preliminary data has found a high frequency of abnormal smears and of inflammatory aspect of the cervix in women with cystic fibrosis. Objectives of the study The main objective of the study is to determine the prevalence of HPV carriage in a cohort of women with cystic fibrosis The secondary objectives are: - To study the factors associated with the prevalence of HPV (transplantation, smoking, age at first intercourse, number of sexual partners in the year, contraception, gravidity and parity, HPV vaccination) - To describe and to compare with data in the general population, in hospital-based population, (and with data in transplanted population for transplanted women) 1. the prevalence of HPV (and of different genotypes) infection, of cervical dysplasia, of vulvar/vaginal/cervical condylomatosis 2. the rate of HPV persistence (> 12 months), the mean time of HPV clearance; rates of spontaneous regression / persistence / worsening of cervical dysplasia Study design: The study will last 24 months. Includable patients are adult women, transplanted or not, followed at Lyon CRCM. Included women will attend a consultation with a gynaecologist. Pap smear test (liquid phase cytology) and genomic DNA microarray assay enabling the detection of 35 different HPV genotypes will be performed. Patients with an initial abnormal pap smear or a positive HPV test will be monitored: - In case of an abnormal smear and / or positive HPV test, pap smear and HPV testing will be renewed every 6 months during the study period - In case of an abnormal smear: Atypical squamous cells of undetermined significance (ASC-US) : the attitude will depend on the result of the HPV test Atypical squamous cells - cannot exclude HSI L (ASC-H), Low-grade squamous intraepithelial lesion (LSIL), High-grade squamous intraepithelial lesion (HSIL), Atypical glandular cell of undetermined significance (AGUS) , Atypical glandular cells (AGC) , Adenoma carcinoma in situ (AIS), carcinoma: a colposcopy will be systematically performed Expected results This study will help to determine the frequency of HPV infection and the pathogenic power of HPV in non-transplanted and in transplanted women with cystic fibrosis This data will help to sensitize health professionals on the importance of gynecological care and regular cervical screening, and on the importance of HPV vaccination. In case of a high frequency of genital diseases linked to HPV, recommendations on gynecological monitoring procedures for women with cystic fibrosis could evolve.

NCT ID: NCT03052062 Completed - Obese Clinical Trials

Tolerance Study of the Dietary Supplement Lipidrive (ECPH1-03)

Start date: March 2, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The objectives of this clinical study are to determine the tolerance of dietary supplement Lipidrive through the evaluation of several parameters : - Various blood biological parameters - Urinary parameters - Hemodynamic indicators - Cardiac function - Anthropometric variables

NCT ID: NCT03050970 Completed - Head Trauma Clinical Trials

Infant Minor Head Trauma Clinical Decision Rule

PELICAN
Start date: February 11, 2017
Phase:
Study type: Observational

The purpose of this study is to validate a clinical decision rule for the management of minor head trauma in infants aged less than two years, constructed with the intention of minimizing the rate of computed tomography scans ordering.

NCT ID: NCT03050073 Completed - Choroidal Thickness Clinical Trials

Choroidal Thickness Association With Primary Angle Closure

Start date: April 18, 2016
Phase:
Study type: Observational [Patient Registry]

A chinese study shows that chinese population eyes with a primary angle closure have a greater choroidal thickness than normal eyes.The increase of choroidal thickness would be associated to this primary angle closure.

NCT ID: NCT03049514 Completed - Clinical trials for Central Retinal Artery Occlusion

Study of Arterial Recanalization of the Central Retinal Artery Occlusions

RECANAL
Start date: December 23, 2016
Phase:
Study type: Observational

Central retinal artery occlusions (CRAO) are the equivalent of an ischemic stroke (IS) at the retinal level. They share the same risk factors and common pathology. Their incidence is lower (8.5 / 100,000) and the functional prognosis is unfavorable in 80% of cases with visual acuity (VA) <1/10. The diagnosis of an CRAO is clinically based on the sudden occurrence of a decrease in deep visual acuity with fundamentally signs of reactive ischemia. There is no data on early retinal arterial recanalization after CRAO, nor on the relationship between early recanalization (spontaneous or post-thrombolysis) and visual prognosis.

NCT ID: NCT03049241 Completed - Clinical trials for Neuromuscular Fatigue

Neuromuscular Fatigue Aetiology Comparison Between Prepubertal Boys and Adults

LENGTH-FATIG
Start date: February 13, 2017
Phase: N/A
Study type: Observational

Potential factors involved in neuromuscular fatigue were classified into two categories: 1) central factors involving the central nervous system and neural pathways, and 2) peripheral factors occurring within the muscle beyond the neuromuscular junction. In adults, it has been shown that peripheral factors contribute to a large part of the fatigue induced by repeated maximal contractions. However in children, central factors could account for the development of fatigue to a greater extent. Force-generating capacity and musculotendinous stiffness could be two of the discriminatory factors accounting for the differences in the neuromuscular fatigue between children and adults. Force production capacity and musculotendinous stiffness vary as function of muscle length. Naturally, they could differ depending on the muscle groups studied. The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults. The investigators formulated the hypotheses that at short muscle length force and low musculotendinous stiffness, differences in force between children and adults would be reduced. Thus neuromuscular fatigue development and aetiology would be similar between both groups. The results of the present protocol will allow to better understanding of the aetiology of neuromuscular fatigue in children and help improving training or rehabilitation programs.

NCT ID: NCT03048604 Completed - Clinical trials for Obstructive Sleep Apnea of Adult

BiLAteral Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnoea (BLAST OSA)

Start date: March 30, 2017
Phase: N/A
Study type: Interventional

The study is designed as a prospective, open-label, multicentre, non-randomized, single arm treatment study to assess the safety, performance and initial efficacy trends of the GenioTM System in patients with Obstructive Sleep Apnoea (OSA).